Selenomethionine and methyl selenocysteine: multiple-dose pharmacokinetics in selenium-replete men

According to the Nutritional Prevention of Cancer (NPC) trial, a selenized yeast supplement containing selenium, 200 mcg/day, decreased the incidence of total cancer, cancers of the prostate, colon and lung, and cancer mortality. The active agent in the selenized yeast supplement was assumed to be s...

Descripción completa

Detalles Bibliográficos
Autores principales: Marshall, James R., Burk, Raymond F., Ondracek, Rochelle Payne, Hill, Kristina E., Perloff, Marjorie, Davis, Warren, Pili, Roberto, George, Saby, Bergan, Raymond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432259/
https://www.ncbi.nlm.nih.gov/pubmed/28412747
http://dx.doi.org/10.18632/oncotarget.15460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432259/
https://www.ncbi.nlm.nih.gov/pubmed/28412747
http://dx.doi.org/10.18632/oncotarget.15460

Ejemplares similares